Premise Health to merge with Crossover Health to expand employer clinicsnews2026-01-29T13:00:02+00:00January 29th, 2026|Endpoints News|
Updated: Roche predicts its breast cancer pill could become its biggest-selling drugnews2026-01-29T12:11:54+00:00January 29th, 2026|Endpoints News|
Following Abivax, Formation Bio licenses miR-124 drug from Chinanews2026-01-29T12:00:49+00:00January 29th, 2026|Endpoints News|
Sanofi says its €15B dealmaking budget, R&D spend should help ease looming Dupixent patent cliffnews2026-01-29T11:46:10+00:00January 29th, 2026|Endpoints News|
Flagship’s Repertoire gets another autoimmune partner in Lillynews2026-01-29T11:30:20+00:00January 29th, 2026|Endpoints News|
